Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the massachusetts data analysis center (Mass-DAC) state registry

American Journal of Kidney Diseases

Volumn 57, Issue 2, 2011, Pages 202-211

  Charytan, David M ^a,b,c   Varma, Manu R ^a   Silbaugh, Treacy S ^c   Lovett, Ann F ^c   Normand, Sharon Lise T ^c,d   Mauri, Laura ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chronic kidney disease; coronary artery disease; drug eluting; stent

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; BARE METAL STENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIALYSIS; DRUG ELUTING STENT; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MASSACHUSETTS; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME;

EID: 78751633264     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.09.017     Document Type: Article

References (40)

1. J. Coresh, E. Selvin, and L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047
2. F. Cardarelli, A. Bellasi, E. Veledar, V. Vaccarino, and P. Raggi Impact of race and chronic kidney disease on 1-year outcome in patients undergoing percutaneous coronary interventions: a single tertiary center experience Am Heart J 155 6 2008 1027 1032
3. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
4. N.S. Anavekar, J.J. McMurray, and E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 13 2004 1285 1295
5. L. Gruberg, G. Dangas, and R. Mehran Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure Catheter Cardiovasc Interv 55 1 2002 66 72
6. C.A. Herzog Poor long-term survival of dialysis patients after acute myocardial infarction: bad treatment or bad disease? Am J Kidney Dis 35 6 2000 1217 1220
7. D. Charytan, J.P. Forman, and D.E. Cutlip Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease Nephrol Dial Transplant 22 9 2007 2578 2585
8. L. Gruberg, N.J. Weissman, and R. Waksman Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency Am J Cardiol 89 1 2002 54 57
9. H.M. Sadeghi, G.W. Stone, and C.L. Grines Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 22 2003 2769 2775
10. N. Attallah, L. Yassine, K. Fisher, and J. Yee Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention Clin Nephrol 64 6 2005 412 418
11. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 14 2003 1315 1323
12. A. Halkin, R. Mehran, and C.W. Casey Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial Am Heart J 150 6 2005 1163 1170
13. E. Schampaert, E.A. Cohen, and M. Schluter The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 6 2004 1110 1115
14. J. Schofer, M. Schluter, and A.H. Gershlick Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 9390 2003 1093 1099
15. P. Das, D.J. Moliterno, and R. Charnigo Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization J Invasive Cardiol 18 9 2006 405 408
16. A. Halkin, F. Selzer, O. Marroquin, W. Laskey, K. Detre, and H. Cohen Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients J Invasive Cardiol 18 12 2006 577 583
17. Y.H. Jeong, M.K. Hong, and C.W. Lee Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation Int J Cardiol 125 1 2008 36 40
18. P.K. Kuchulakanti, R. Torguson, and W.W. Chu Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents Am J Cardiol 97 6 2006 792 797
19. T. Ota, H. Umeda, and S. Yokota Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation Am Heart J 158 1 2009 92 98
20. D.T. Gilbertson, A.S. Craig, L.X. Jay, and A.J. Collins Projecting the U.S. ESRD population to 2030 [abstract] J Am Soc Nephrol 14 2003 (abstracts):F-PO881
21. Y. Kiyota, S. Schneeweiss, R.J. Glynn, C.C. Cannuscio, J. Avorn, and D.H. Solomon Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records Am Heart J 148 1 2004 99 104
22. L. Mauri, T.S. Silbaugh, and P. Garg Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 13 2008 1330 1342
23. X.S. Gu, and P.R. Rosenbaum Comparison of multivariate matching methods: structures, distances, and algorithms J Comput Graph Stat 2 1993 405 420
24. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 3 2004 221 231
25. P. Garg, S.L. Normand, and T.S. Silbaugh Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry Circulation 118 22 2008 2277 2285 7p following 2285
26. F. Latif, N.S. Kleiman, and D.J. Cohen In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry JACC Cardiovasc Interv 2 1 2009 37 45
27. P.J. Best, R. Lennon, and H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 7 2002 1113 1119
28. H. Sasao, D. Hotta, T. Maeda, N. Saito, S. Takagi, and K. Shimamoto Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodialysis Int Heart J 48 6 2007 689 700
29. T. Aoyama, H. Ishii, and T. Toriyama Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis Circ J 72 1 2008 56 60
30. N. Ishio, Y. Kobayashi, and H. Takebayashi Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients Circ J 71 10 2007 1525 1529
31. C.E. Appleby, J. Ivanov, and S. Lavi The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era Circ Cardiovasc Interv 2 4 2009 309 316
32. P. Garg, D.M. Charytan, and L. Novack Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation: results from the SIRIUS trials Am J Cardiol 2010 In press
33. J. Sosnov, D. Lessard, R.J. Goldberg, J. Yarzebski, and J.M. Gore Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective Am J Kidney Dis 47 3 2006 378 384
34. D. Charytan, L. Mauri, A. Agarwal, S. Servoss, B. Scirica, and R.E. Kuntz The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients Am Heart J 152 3 2006 558 564
35. G.M. Chertow, S.L. Normand, and B.J. McNeil "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency J Am Soc Nephrol 15 9 2004 2462 2468
36. N. Joki, H. Hase, R. Nakamura, and T. Yamaguchi Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease Nephrol Dial Transplant 12 4 1997 718 723
37. T. Ohtake, S. Kobayashi, and H. Moriya High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination J Am Soc Nephrol 16 4 2005 1141 1148
38. P. Raggi, A. Boulay, and S. Chasan-Taber Cardiac calcification in adult hemodialysis patients A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39 4 2002 695 701
39. H. Shimizu, Y. Hirose, F. Nishijima, Y. Tsubakihara, and H. Miyazaki ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration Am J Physiol Cell Physiol 297 2 2009 C389 C396
40. T. Gunthner, V. Jankowski, and A. Kretschmer Endothelium and vascular smooth muscle cells in the context of uremia Semin Dial 22 4 2009 428 432